Ondansetron has similar clinical efficacy against both nausea and vomiting


Jokela R. M. , Cakmakkaya O. S. , Danzeisen O., Korttila K. T. , Kranke P., Malhotra A., ...Daha Fazla

ANAESTHESIA, cilt.64, ss.147-151, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Ondansetron is widely believed to prevent postoperative vomiting more effectively than nausea. We analysed data from 5161 patients undergoing general anaesthesia who were randomly stratified to receive a combination of six interventions, one of which was 4 mg ondansetron vs placebo. For the purpose of this study a 20% difference in the relative risks for the two outcomes was considered clinically relevant. Nausea was reduced from 38% (969/2585) in the control to 28% (715/2576) in the ondansetron group, corresponding to a relative risk of 0.74, or a relative risk reduction of 26%. Vomiting was reduced from 17% (441/2585) to 11% (293/2576), corresponding to a relative risk of 0.67, or a relative risk reduction of 33%. The relative risks of 0.67 and 0.74 were clinically similar and the difference between them did not reach statistical significance. We thus conclude that ondansetron prevents postoperative nausea and postoperative vomiting equally well.